Reyes Guillermo, Fernández-Yáñez Juan, Rodríguez-Abella Hugo, Palomo Jesús, Pinto Angel, Duarte Juan
Servicio de Cirugía Cardiovascular, Hospital Universitario La Princesa, Madrid, Spain.
Rev Esp Cardiol. 2007 Jan;60(1):72-5.
We carried out an analysis of the results obtained in patients (n=23) who received a ventricular assist device before heart transplantation between 1988 and 2005. Their mean age was 52.5 (8.4) years. Reasons for inclusion in the transplantation waiting list were postcardiotomy referral (n=10), myocardial infarction (n=5), primary graft dysfunction (n=7), and dilated cardiomyopathy (n=1). Different types of ventricular assist device were used: the Abiomed 5000 (n=13), the Biomed Comunidad de Madrid (n=9), and the BioMedicus (n=1). The mean transplantation waiting time was 3.0 (2.4) days. In-hospital complications were neurological (n=7), infectious (n=12), renal (n=3), hemorrhagic (n=3), and respiratory (n=2). In-hospital mortality was 39.1% (n=9). Kaplan-Meier analysis gave a 1-year survival rate of 55.2% and a 5-year survival rate of 32.2%. In patients who were discharged home, the 1-year survival rate was 92.3%. Careful patient selection is essential for obtaining good results.
我们对1988年至2005年间在心脏移植前接受心室辅助装置的患者（n = 23）所获得的结果进行了分析。他们的平均年龄为52.5（8.4）岁。列入移植等候名单的原因有心内直视手术后转诊（n = 10）、心肌梗死（n = 5）、原发性移植物功能障碍（n = 7）和扩张型心肌病（n = 1）。使用了不同类型的心室辅助装置：Abiomed 5000（n = 13）、马德里自治区生物医学装置（n = 9）和百特生物医学公司的装置（n = 1）。平均移植等候时间为3.0（2.4）天。住院并发症包括神经方面（n = 7）、感染方面（n = 12）、肾脏方面（n = 3）、出血方面（n = 3）和呼吸方面（n = 2）。住院死亡率为39.1%（n = 9）。Kaplan-Meier分析得出1年生存率为55.2%，5年生存率为32.2%。出院回家的患者1年生存率为92.3%。仔细的患者选择对于获得良好结果至关重要。
